We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

52 hedge funds and large institutions have $37.9M invested in Applied Genetic Technologies Corporation in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $34.1M → $37.9M (+$3.77M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 5552 (-3)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
12
Reduced
15
Closed
10
Calls
$264K
Puts
Net Calls
+$264K
Net Calls Change
-$60K
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
-$228K -54,702 Closed
FAM
52
Fred Alger Management
New York
-$146K -35,000 Closed
Millennium Management
53
Millennium Management
New York
-$79K -19,168 Closed
LPL Financial
54
LPL Financial
California
-$71K -17,000 Closed
AG
55
Algert Global
California
-$61K -14,740 Closed
ZIM
56
Zacks Investment Management
Illinois
-$43K -10,256 Closed
HIM
57
Hillsdale Investment Management
Ontario, Canada
-$25K -6,100 Closed
Victory Capital Management
58
Victory Capital Management
Texas
-$8K -2,015 Closed
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
-$2K -575 Closed
Federated Hermes
60
Federated Hermes
Pennsylvania
-$2K -483 Closed
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
-$114 -36 -92%
Barclays
62
Barclays
United Kingdom
+$22 +7 New

AGTC Hedge Fund Activity: Q4 2019 in Review

52 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2019, worth a combined $37.9M — up 11% from $34.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AGTC and 7 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $516K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $228K sold.

  • 52 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2019, down from 55 in Q3 2019.
  • Funds reported $37.9M of Applied Genetic Technologies Corporation stock for Q4 2019, up 11% quarter-over-quarter.
  • 7 funds opened new Applied Genetic Technologies Corporation positions in Q4 2019 and 10 closed out, a net change of -3 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $516K added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2019 was D.E. Shaw & Co, an estimated $228K sold.

Based on aggregated 13F filings for Q4 2019.